AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 83 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,158,040 | +84786.2% | 2,084,000 | 0.0% | 2.03% | -2.6% |
| Q2 2023 | $44,952 | -26.5% | 2,084,000 | 0.0% | 2.08% | -30.6% |
| Q1 2023 | $61,145 | -99.9% | 2,084,000 | 0.0% | 3.00% | -26.0% |
| Q4 2022 | $77,003,800 | +31.3% | 2,084,000 | 0.0% | 4.06% | +23.0% |
| Q3 2022 | $58,665,000 | +38.5% | 2,084,000 | -5.3% | 3.30% | +22.9% |
| Q2 2022 | $42,372,000 | +49.9% | 2,200,000 | 0.0% | 2.68% | +84.7% |
| Q1 2022 | $28,270,000 | – | 2,200,000 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |